A new mesalazine foam enema (Claversal Foam) compared with a standard liquid enema in patients with active distal ulcerative colitis.
about
Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitisMucosal healing and deep remission: what does it mean?Efficacy and safety of rectal 5-aminosalicylic acid versus corticosteroids in active distal ulcerative colitis: a systematic review and network meta-analysisIndications for 5-aminosalicylate in inflammatory bowel disease: is the body of evidence complete?Histological healing after infliximab induction therapy in children with ulcerative colitisThe risks and the benefits of mesalazine as a treatment for ulcerative colitis.Quality of life of patients with ulcerative colitis: past, present, and future.Therapeutic strategies for the management of ulcerative colitis.High mucosal healing rates in 5-ASA-treated ulcerative colitis patients: results of a meta-analysis of clinical trials.Topical therapy.Current evidence supporting mucosal healing and deep remission as important treatment goals for inflammatory bowel disease.Ulcerative proctitis.Histological healing in inflammatory bowel disease: a still unfulfilled promise.A new oral delivery system for 5-ASA: preliminary clinical findings for MMx.Budesonide foam versus budesonide enema in active ulcerative proctitis and proctosigmoiditis.
P2860
Q24240567-482258F6-0700-4028-ADE6-8DF1AECEBF24Q26852447-BE69CC9B-641E-49F0-8C7F-6AD5DD3FC149Q33600845-61FF990F-61F2-44FC-83AE-AE84C38793F2Q33868970-78490781-3896-4688-ADAB-5D958B70DDF3Q36105637-7880FE66-2559-496A-871B-8CEE5B739DA5Q36762423-C4385C9A-E7C3-4D24-9C34-84D4BC11D330Q36987080-B7069733-5148-45EE-8831-C682CBD08CC0Q37318035-25C62CD3-385F-424B-9BAB-E76E41340917Q37993821-037770EB-9F43-4780-9DCA-4E97F74EF60BQ38072231-031E7972-01A8-4678-B0D4-6C4A5EC2C146Q38797791-A61523B3-9661-4FA2-807B-1BD7A99128F2Q42652328-0D3EF83D-9635-401E-8AD6-70B5D2A934B2Q43240077-70D90AF7-A950-4CD1-951E-D0EEB9554E36Q46469247-EFBF49A4-07EC-4279-98FB-7C8C64BB301AQ46879647-D11A26D3-9D70-47D2-AED8-29773F5DBA03
P2860
A new mesalazine foam enema (Claversal Foam) compared with a standard liquid enema in patients with active distal ulcerative colitis.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
A new mesalazine foam enema (C ...... ive distal ulcerative colitis.
@en
A new mesalazine foam enema
@nl
type
label
A new mesalazine foam enema (C ...... ive distal ulcerative colitis.
@en
A new mesalazine foam enema
@nl
prefLabel
A new mesalazine foam enema (C ...... ive distal ulcerative colitis.
@en
A new mesalazine foam enema
@nl
P2093
P2860
P1476
A new mesalazine foam enema (C ...... ive distal ulcerative colitis.
@en
P2093
CLAFOAM Study group
P2860
P304
P356
10.1046/J.1365-2036.2002.01199.X
P407
P577
2002-03-01T00:00:00Z